Leukaemia Research

NCI-supported specialists are attempting to propel our comprehension of how to treat leukemia. With propels in both focused on treatments and immunotherapies, leukemia treatment can possibly turn out to be progressively successful and less poisonous.

This page features probably the most recent exploration in leukemia, including clinical advances that may before long convert into improved consideration, NCI-bolstered programs that are energizing advancement, and examination discoveries from late investigations.

The pillars of leukemia treatment for grown-ups have been chemotherapy, radiation treatment, and undifferentiated cell transplantation. In the course of the most recent two decades, directed treatments have likewise become piece of the standard of care for certain kinds of leukemia. Various sorts of leukemia require various mixes of treatments.

High Impact List of Articles

Future prospects for DLBCL treatment: Combination of WEE1 inhibitors with CHOP and radiation therapy
Tom van Meerten, Mathilde Rikje Willemijn de Jong, Lydia Visser
Short Communication: Hematology and Blood Disorders
Future prospects for DLBCL treatment: Combination of WEE1 inhibitors with CHOP and radiation therapy
Tom van Meerten, Mathilde Rikje Willemijn de Jong, Lydia Visser
Short Communication: Hematology and Blood Disorders
Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny
Shimon Slavin
Market Analysis: Hematology and Blood Disorders
Breakthrough notions in Hematology and Transfusion Medicine: Market Scrutiny
Shimon Slavin
Market Analysis: Hematology and Blood Disorders
Comparing methods of tranexamic acid administration and blood reinfusion in reducing blood loss during total knee arthroplasty.
Mingyang Yu, Bowu Luan, Simiao Tian, Guishan Gu
Research Article: Hematology and Blood Disorders
Comparing methods of tranexamic acid administration and blood reinfusion in reducing blood loss during total knee arthroplasty.
Mingyang Yu, Bowu Luan, Simiao Tian, Guishan Gu
Research Article: Hematology and Blood Disorders
Next-generation sequencing: emerging technology in the area of hematology and blood disorder.
Prabhakar S Kedar
Short Communication: Hematology and Blood Disorders
Next-generation sequencing: emerging technology in the area of hematology and blood disorder.
Prabhakar S Kedar
Short Communication: Hematology and Blood Disorders
Maternal RBC alloantibodies in pregnancy
Ehsan Shahverdi, Ghazaleh Salehabadi
Editorial: Hematology and Blood Disorders
Maternal RBC alloantibodies in pregnancy
Ehsan Shahverdi, Ghazaleh Salehabadi
Editorial: Hematology and Blood Disorders

Conference Proceedings

Percutaneous dilatational tracheostomy and modifications in intensive care unit patients
Ashraf Ahmed Yakoot EL-Bedeiwy, Rasha Mohamed Elsayed, Mohamed Mourad and Mohamed Mohsen Rasheed
Scientific Tracks Abstracts: Otolaryngology Online Journal
Percutaneous dilatational tracheostomy and modifications in intensive care unit patients
Ashraf Ahmed Yakoot EL-Bedeiwy, Rasha Mohamed Elsayed, Mohamed Mourad and Mohamed Mohsen Rasheed
Scientific Tracks Abstracts: Otolaryngology Online Journal
Assessment of vascular stiffness and relation to cardiovascular risk factors in patients with SLE
Moataz Taha
Posters & Accepted Abstracts: Current Trends in Cardiology
The efficacy of tocotrienols in the treatment of non-alcoholic steatohepatitis: A systematic review
Higinio T Mappala
Keynote: Journal of Gastroenterology and Digestive Diseases
The efficacy of tocotrienols in the treatment of non-alcoholic steatohepatitis: A systematic review
Higinio T Mappala
Keynote: Journal of Gastroenterology and Digestive Diseases
Inhibition of protein tyrosine phosphatase 1B in vitro and in vivo
Marvin W Makinen
Keynote: Journal of Pharmacology and Therapeutic Research
Inhibition of protein tyrosine phosphatase 1B in vitro and in vivo
Marvin W Makinen
Keynote: Journal of Pharmacology and Therapeutic Research
Improved drug delivery and therapeutic efficacy of PEGylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model
Masoumeh Zahmatkeshan
Posters & Accepted Abstracts: Biology & Medicine Case Reports
Improved drug delivery and therapeutic efficacy of PEGylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model
Masoumeh Zahmatkeshan
Posters & Accepted Abstracts: Biology & Medicine Case Reports